NCT00274248
- Conditions
- Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.
NCT00274248
NCT00257114
NCT00383318
NCT00463593
NCT00599937
Not specified
NCT00549484
NCT00123656
NCT00090090
NCT00593801
NCT00591526
Not specified